UAE Biopharmaceutical Third-party Logistics Market Size & Outlook
UAE biopharmaceutical third-party logistics market, 2018-2030 (US$M)
Related Markets
UAE biopharmaceutical third-party logistics market highlights
- The UAE biopharmaceutical third-party logistics market generated a revenue of USD 1,456.8 million in 2024 and is expected to reach USD 1,797.3 million by 2030.
- The UAE market is expected to grow at a CAGR of 3.6% from 2025 to 2030.
- In terms of segment, non-cold chain logistics was the largest revenue generating supplychain in 2024.
- Cold Chain Logistics is the most lucrative supplychain segment registering the fastest growth during the forecast period.
Biopharmaceutical third-party logistics market data book summary
| Market revenue in 2024 | USD 1,456.8 million |
| Market revenue in 2030 | USD 1,797.3 million |
| Growth rate | 3.6% (CAGR from 2025 to 2030) |
| Largest segment | Non-cold chain logistics |
| Fastest growing segment | Cold Chain Logistics |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cold Chain Logistics, Non-cold Chain Logistics |
| Key market players worldwide | DHL Group, SF Express, United Parcel Service Inc Class B, AmerisourceBergen Drug Corporation, DB Schenker, Kuehne + Nagel International AG, Kerry Logistics Network Ltd, Agility |
Other key industry trends
- In terms of revenue, UAE accounted for 1.0% of the global biopharmaceutical third-party logistics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia biopharmaceutical third-party logistics market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 1,797.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopharmaceutical Third-party Logistics Market Scope
Biopharmaceutical Third-party Logistics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE biopharmaceutical third-party logistics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical third-party logistics market will help companies and investors design strategic landscapes.
Non-cold chain logistics was the largest segment with a revenue share of 81.59% in 2024. Horizon Databook has segmented the UAE biopharmaceutical third-party logistics market based on cold chain logistics, non-cold chain logistics covering the revenue growth of each sub-segment from 2018 to 2030.
The UAE biopharmaceutical third party logistics market accounted for 28.8% market share in 2020 in the MEA market. According to the World Bank, the U.S. had a modest Logistics Performance Index (LPI) score of 3.96 in 2018.
The country also has a modest transportation sector. In 2021, Emirates SkyCargo underwent an agreement with UNICEF for the transport of COVID-19 vaccines. Emirates SkyCargo setup in Dubai can store up to 10 million doses of vaccine at a temperature range of two to 8°C.
Reasons to subscribe to UAE biopharmaceutical third-party logistics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UAE biopharmaceutical third-party logistics market databook
-
Our clientele includes a mix of biopharmaceutical third-party logistics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE biopharmaceutical third-party logistics market , including forecasts for subscribers. This country databook contains high-level insights into UAE biopharmaceutical third-party logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UAE biopharmaceutical third-party logistics market size, by supplychain, 2018-2030 (US$M)
UAE Biopharmaceutical Third-party Logistics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
